Join to View Full Profile
4701 Ogletown Stanton RdSte 2300Newark, DE 19713
Are you Dr. Alzoubi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ammar Alzoubi, MD is an oncologist in Newark, Delaware. He is currently licensed to practice medicine in Delaware, New York, and Minnesota.
Education & Training
UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 1998 - 2001
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1995 - 1998
University of Aleppo Faculty of MedicineClass of 1988
Certifications & Licensure
DE State Medical License 2022 - 2027
MN State Medical License 2012 - 2023
ND State Medical License 2012 - 2023
NY State Medical License 2018 - 2023
MI State Medical License 2005 - 2015
MA State Medical License 1999 - 2006
WI State Medical License 1997 - 2001
American Board of Internal Medicine Hematology- Join now to see all
Publications & Presentations
PubMed
- 1 citationsClinical problem-solving. Diagnosing one letter at a time.Christopher Smith, Sanjay Saint, Raymond S. Price, Ammar Al-Zoubi, Brian C. Callaghan
The New England Journal of Medicine. 2015-01-01 - 35 citationsCarfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myelomaDominik Dytfeld, Jagoda Jasielec, Kent A. Griffith, Daniel Lebovic, David H. Vesole
Haematologica. 2014-09-01 - 346 citationsA phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myelomaAndrzej Jakubowiak, Dominik Dytfeld, Kent A. Griffith, Daniel Lebovic, David H. Vesole
Blood. 2012-08-30
Press Mentions
Sanford Health Completes North Dakota's First Bone Marrow TransplantNovember 17th, 2021
